Skip to content
lifestyle.microcapnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Generate:Biomedicines
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
May 28, 2026
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 26, 2026
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
December 1, 2025